Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal changes in visual acuity in keratoconus.
Davis LJ, Schechtman KB, Wilson BS, Rosenstiel CE, Riley CH, Libassi DP, Gundel RE, Rosenberg L, Gordon MO, Zadnik K; Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Davis LJ, et al. Among authors: riley ch. Invest Ophthalmol Vis Sci. 2006 Feb;47(2):489-500. doi: 10.1167/iovs.05-0381. Invest Ophthalmol Vis Sci. 2006. PMID: 16431941
Baseline factors predictive of incident penetrating keratoplasty in keratoconus.
Gordon MO, Steger-May K, Szczotka-Flynn L, Riley C, Joslin CE, Weissman BA, Fink BA, Edrington TB, Olafsson HE, Zadnik K; Clek Study Group. Gordon MO, et al. Am J Ophthalmol. 2006 Dec;142(6):923-30. doi: 10.1016/j.ajo.2006.07.026. Epub 2006 Sep 1. Am J Ophthalmol. 2006. PMID: 17157577
The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets.
Holmström MO, Ruders JH, Riley CH, Larsen MK, Grauslund JH, Kjær L, Skov V, Ellervik C, Guo BB, Linden M, Hasselbalch HC, Andersen MH. Holmström MO, et al. Among authors: riley ch. Br J Haematol. 2024 Oct;205(4):1417-1429. doi: 10.1111/bjh.19711. Epub 2024 Aug 20. Br J Haematol. 2024. PMID: 39161981
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment.
Sørensen AL, Bjørn ME, Riley CH, Holmstrøm M, Andersen MH, Svane IM, Mikkelsen SU, Skov V, Kjaer L, Hasselbalch HC, Nielsen CH. Sørensen AL, et al. Among authors: riley ch. Eur J Haematol. 2019 Oct;103(4):351-361. doi: 10.1111/ejh.13292. Epub 2019 Aug 18. Eur J Haematol. 2019. PMID: 31297883 Clinical Trial.
Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response.
Holmström MO, Riley CH, Skov V, Svane IM, Hasselbalch HC, Andersen MH. Holmström MO, et al. Among authors: riley ch. Oncoimmunology. 2018 Feb 27;7(6):e1433521. doi: 10.1080/2162402X.2018.1433521. eCollection 2018. Oncoimmunology. 2018. PMID: 29872567 Free PMC article.
30 results